Nucleic Acids Research Advance Access published online on September 23, 2008
Nucleic Acids Research, doi:10.1093/nar/gkn598
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Biology |
14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers
MRC Laboratory of Molecular Biology and MRC Centre for Protein Engineering, Hills Road, Cambridge, CB2 0QH, UK
*To whom correspondence should be addressed. Tel: +44 1223 402 137; Fax: +44 1223 402 140; Email: arf25{at}cam.ac.uk
Received August 7, 2008. Revised September 1, 2008. Accepted September 3, 2008.
Activation of the tumour suppressor p53 on DNA damage involves post-translational modification by phosphorylation and acetylation. Phosphorylation of certain residues is critical for p53 stabilization and plays an important role in DNA-binding activity. The 14-3-3 family of proteins activates the DNA-binding affinity of p53 upon stress by binding to a site in its intrinsically disordered C-terminal domain containing a phosphorylated serine at 378. We have screened various p53 C-terminal phosphorylated peptides for binding to two different isoforms of 14-3-3, 
and 
. We found that phosphorylation at either S366 or T387 caused even tighter binding to 14-3-3. We made by semi-synthesis a tetrameric construct comprised of the tetramerization plus C-terminal domains of p53 that was phosphorylated on S366, S378 and T387. It bound 10 times tighter than did the monomeric counterpart to dimeric 14-3-3. We showed indirectly from binding curves and directly from fluorescence-detection analytical ultracentrifugation that 14-3-3 enhanced the binding of sequence-specific DNA to p53 by causing p53 dimers to form tetramers at lower concentrations. If the in vitro data extrapolate to in vivo, then it is an attractive hypothesis that p53 activity may be subject to control by accessory proteins lowering its tetramer–dimer dissociation constant from its normal value of 120–150 nM.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Rajagopalan, R. S. Sade, F. M. Townsley, and A. R. Fersht Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms Nucleic Acids Res., November 20, 2009; (2009) gkp1041v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Natan, D. Hirschberg, N. Morgner, C. V. Robinson, and A. R. Fersht Ultraslow oligomerization equilibria of p53 and its implications PNAS, August 25, 2009; 106(34): 14327 - 14332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rajagopalan, A. Andreeva, D. P. Teufel, S. M. Freund, and A. R. Fersht Interaction between the Transactivation Domain of p53 and PC4 Exemplifies Acidic Activation Domains as Single-stranded DNA Mimics J. Biol. Chem., August 7, 2009; 284(32): 21728 - 21737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. van Dieck, M. R. Fernandez-Fernandez, D. B. Veprintsev, and A. R. Fersht Modulation of the Oligomerization State of p53 by Differential Binding of Proteins of the S100 Family to p53 Monomers and Tetramers J. Biol. Chem., May 15, 2009; 284(20): 13804 - 13811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-H. Cai, J.-Y. Chen, M.-H. Lu, L.-T. Chang, H.-C. Lin, Y.-M. Chang, and C.-F. Chao Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53 Nucleic Acids Res., April 1, 2009; 37(6): 1984 - 1990. [Abstract] [Full Text] [PDF]
|
|